Shigenobu Kanba
- Psychiatry and Mental health top 0.2%
- Clinical Psychology top 0.5%
- Cognitive Neuroscience top 0.5%
- Biological Psychiatry top 0.05%
- Neurology top 0.2%
- Co-authors
- Takahiro A. KatoAkira MonjiGohei YagiToshio NakakiToru IwakiAlan R. TeoYutaka KiyoharaJun Hata
- Topics
- Tryptophan and brain disorders (46 papers)Schizophrenia research and treatment (44 papers)Neuroinflammation and Neurodegeneration Mechanisms (39 papers)
- Partner nations
- JapanUnited StatesMalaysia
In The Last Decade
Shigenobu Kanba
317 papers receiving 13.7k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Psychiatry and Mental health 3.4k
- Clinical Psychology 2.7k
- Cognitive Neuroscience 2.6k
- Biological Psychiatry 2.4k
- Neurology 2.1k
Countries citing papers authored by Shigenobu Kanba
This map shows the geographic impact of Shigenobu Kanba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigenobu Kanba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigenobu Kanba more than expected).
Fields of papers citing papers by Shigenobu Kanba
This network shows the impact of papers produced by Shigenobu Kanba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigenobu Kanba. The network helps show where Shigenobu Kanba may publish in the future.
Co-authorship network of co-authors of Shigenobu Kanba
This figure shows the co-authorship network connecting the top 25 collaborators of Shigenobu Kanba. A scholar is included among the top collaborators of Shigenobu Kanba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigenobu Kanba. Shigenobu Kanba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 32 | |
| 3 | 17 | |
| 4 | 104 | |
| 5 | 16 | |
| 6 | 6 | |
| 7 | 18 | |
| 8 | 17 | |
| 9 | Antidepressant Prescription Pattern in the Presence of Medical Co-morbidity: REAP-AD 2013 Study. | 1 |
| 10 | 31 | |
| 11 | 12 | |
| 12 | 52 | |
| 13 | 19 | |
| 14 | 48 | |
| 15 | A randomized, controlled, multicenter trial of post-suicide attempt intervention for the prevention of further attempts in Japan | 2 |
| 16 | 13 | |
| 17 | 35 | |
| 18 | 64 | |
| 19 | Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders. | 10 |
| 20 | 15 |
About Shigenobu Kanba
Shigenobu Kanba is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Psychiatry and Mental health, having authored 324 papers that have together received 14.1k indexed citations. Recurring topics across this work include Tryptophan and brain disorders (46 papers), Schizophrenia research and treatment (44 papers) and Neuroinflammation and Neurodegeneration Mechanisms (39 papers). The work is most often cited by research in Biological Psychiatry (2.4k citations), Behavioral Neuroscience (1.5k citations) and Neurology (2.1k citations). Shigenobu Kanba has collaborated with scholars based in Japan, United States and Malaysia. Frequent co-authors include Takahiro A. Kato, Akira Monji, Gohei Yagi, Toshio Nakaki, Toru Iwaki, Alan R. Teo, Yutaka Kiyohara, Jun Hata, Sadayuki Hashioka and Tomohiro Nakao. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.